Cholesterol is one of the main components of cell membranes and is essential for the synthesis of various hormones. For this reason, it is vital for life; however, when not properly managed, it can pose risks to cardiovascular health. Hypercholesterolemia—particularly elevated LDL cholesterol—is a modifiable, independent cardiovascular risk factor. Ten million Italians have mild to moderate dyslipidemia (ISS data), yet half are unaware of it. Cholesterol must be assessed, together with other risk factors, within the framework of overall cardiovascular risk, which represents the absolute probability of experiencing a cardiovascular event (such as myocardial infarction or stroke) within a defined time frame, typically 10 years. A preventive approach from a young age—based on healthy eating, weight control, and regular physical activity—is essential to help maintain LDL cholesterol levels within normal ranges.
To support the maintenance of healthy cholesterol levels, the use of specifically formulated nutraceuticals may be considered. In this context, scientific research and innovation—pillars of Dompé’s expertise—have led to the development of an advanced, effective, and well‑tolerated product, Cardioritmon Colesterolo®, providing a concrete option for primary cardiovascular prevention. Scientific evidence plays a key role in supporting physicians in evaluating the formulation within their clinical practice.